Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Alter

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
Patient Preference and Adherence|August 4, 2022
Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONETCarolina Fischer, Rudolf A Jörres, Peter Alter, et al.
International Journal of Cardiology|April 17, 2018
Left ventricular volume and wall stress are linked to lung function impairment in COPDPeter Alter, Rudolf A Jörres, Henrik Watz, et al.
Journal of Rehabilitation Medicine|January 26, 2016
Whole-body vibration therapy in intensive care patients: A feasibility and safety studyTobias Boeselt, Christoph Nell, Katahrina Kehr, et al.
Respiration; International Review of Thoracic Diseases|February 7, 2021
Prognostic Value of Oxygenated Hemoglobin Assessed during Acute Exacerbations of Chronic Pulmonary DiseaseClemens F Hinke, Rudolf A Jörres, Peter Alter, et al.
Respiratory Medicine Case Reports|September 6, 2019
Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussionKhodr Tello, Andreas Hoffmann, Björn Beutel, et al.
Chronic Respiratory Disease|May 11, 2018
Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scansKathrin Kahnert, Bertram Jobst, Frank Biertz, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2023
Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohortPeter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 2, 2021
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONETKathrin Kahnert, Rudolf A Jörres, Tanja Lucke, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 3, 2019
Personalized medicine for patients with COPD: where are we?Frits Me Franssen, Peter Alter, Nadav Bar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2021
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort - Determinants and ConsequencesJohanna I Lutter, Rudolf A Jörres, Franziska C Trudzinski, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Patient Preference and Adherence|August 4, 2022
Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONETCarolina Fischer, Rudolf A Jörres, Peter Alter, et al.
International Journal of Cardiology|April 17, 2018
Left ventricular volume and wall stress are linked to lung function impairment in COPDPeter Alter, Rudolf A Jörres, Henrik Watz, et al.
Journal of Rehabilitation Medicine|January 26, 2016
Whole-body vibration therapy in intensive care patients: A feasibility and safety studyTobias Boeselt, Christoph Nell, Katahrina Kehr, et al.
Respiration; International Review of Thoracic Diseases|February 7, 2021
Prognostic Value of Oxygenated Hemoglobin Assessed during Acute Exacerbations of Chronic Pulmonary DiseaseClemens F Hinke, Rudolf A Jörres, Peter Alter, et al.
Respiratory Medicine Case Reports|September 6, 2019
Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussionKhodr Tello, Andreas Hoffmann, Björn Beutel, et al.
Chronic Respiratory Disease|May 11, 2018
Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scansKathrin Kahnert, Bertram Jobst, Frank Biertz, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2023
Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohortPeter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 2, 2021
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONETKathrin Kahnert, Rudolf A Jörres, Tanja Lucke, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 3, 2019
Personalized medicine for patients with COPD: where are we?Frits Me Franssen, Peter Alter, Nadav Bar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2021
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort - Determinants and ConsequencesJohanna I Lutter, Rudolf A Jörres, Franziska C Trudzinski, et al.
Pageof 15